目錄:MedChemExpress LLC>>生化試劑>> DTP3 | MCE
CAS | 1809784-29-9 | 純度 | 99.43% |
---|---|---|---|
分子量 | 525.6 | 分子式 | C??H??N?O? |
供貨周期 | 現(xiàn)貨 | 規(guī)格 | 10 mg |
貨號 | HY-100538 | 應用領域 | 醫(yī)療衛(wèi)生,化工,生物產(chǎn)業(yè),制藥 |
MCE 的所有產(chǎn)品僅用作科學研究或藥證申報,我們不為任何個人用途提供產(chǎn)品和服務。
CAS No. : 1809784-29-9
產(chǎn)品活性:DTP3 TFA is a potent and selective GADD45β/MKK7 inhibitor. DTP3 TFA targets an essential, cancer-selective cell-survival module downstream of the NF-κB pathway.
研究領域:Cell Cycle/DNA Damage | JAK/STAT Signaling | Stem Cell/Wnt | Epigenetics | Protein Tyrosine Kinase/RTK
作用靶點:DNA/RNA Synthesis | JAK
In Vitro: DTP3 (10 μM; 1-21 days) causes the potent and tumor-selective induction of JNK activation and apoptosis, as shown by the appearance of phosphorylated JNK, as early as 24 hours.
In Vivo: DTP3 TFA (s.c.; 14.5 mg/kg/day; 28 days) has shown a dramatic shrinkage of the tumors, and virtually eradicates established subcutaneous myeloma xenografts in mice.
DTP3 TFA (intravenous injection; 10 mg/kg/day) has t1/2 of 1.26 hours, CL of 27.13 ML/min/kg, and Vd of 2.80 L/kg.
相關產(chǎn)品:Bioactive Compound Library Plus | Cell Cycle/DNA Damage Compound Library | Epigenetics Compound Library | Immunology/Inflammation Compound Library | JAK/STAT Compound Library | Kinase Inhibitor Library | NF-κB Signaling Compound Library | Protein Tyrosine Kinase Compound Library | Stem Cell Signaling Compound Library | Anti-Cancer Compound Library | Anti-Aging Compound Library | Differentiation Inducing Compound Library | Reprogramming Compound Library | Anti-Breast Cancer Compound Library | Anti-Lung Cancer Compound Library | Anti-Pancreatic Cancer Compound Library | Anti-Blood Cancer Compound Library | Anti-Obesity Compound Library | Targeted Diversity Library | Anti-Liver Cancer Compound Library | Peptide Library | Anti-Prostate Cancer Compound Library | Cancer Stem Cells Compound Library | IBU-DC Phosphoramidite | JAK-IN-20 | 2,4-D sodium salt | Thailanstatin D | Carboplatin-d4 | Caracemide | JAK1-IN-9 | Farudodstat | AT9283 | RO495 | TK4b | JAK-IN-17 | (E/Z)-Zotiraciclib | DNA31 | 2'-OMe-Ac-C Phosphoramidite | JAK-IN-10 | Dasabuvir | DNA Gyrase-IN-4 | Uridine triphosphate-13C9,15N2 (sodium) | 5-Methylcytosine | Cidofovir dihydrate | Capecitabine-d11 | Tezacitabine | (3R,4S)-Tofacitinib | JAK3/BTK-IN-6 | Mequindox | 5-Methylcytosine-d4 | TH287 hydrochloride | DNA Gyrase-IN-1 | Tyk2-IN-5
熱門產(chǎn)品線:重組蛋白 | 化合物庫 | 天然產(chǎn)物 | 熒光染料 | PROTAC | 同位素標記物 | 寡核苷酸 | 抗體 | 點擊化學
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介紹:
• MCE (MedChemExpress) 擁有200 多種全球僅有化合物庫,我們致力于為全球科研客戶提供前沿的高品質(zhì)小分子活性化合物;
• 50,000 多種高選擇性抑制劑、激動劑涉及各熱門信號通路及疾病領;
• 產(chǎn)品種類涵蓋各種重組蛋白,多肽,常用試劑盒 ,更有 PROTAC、ADC 等特色產(chǎn)品,廣泛應用于新藥研發(fā)、生命科學等科研項目;
• 提供虛擬篩選,離子通道篩選,代謝組學分析檢測分析,藥物篩選等專業(yè)技術服務;
• 設有專業(yè)的實驗中心和嚴格的質(zhì)控、驗證體系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項質(zhì)檢報告,確保產(chǎn)品的高純度、高品質(zhì);
• 產(chǎn)品的生物活性多經(jīng)各國客戶實驗驗證;
• Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果;
• 專業(yè)團隊跟蹤最新的制藥及生命科學研究進展,為您提供全球新的活性化合物;
• 與世界各大制藥公司及著名科研機構建立了長期的合作。